Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

New England Journal of Medicine - Tập 384 Số 1 - Trang 20-30 - 2021
Carlos Salama1, Jian Han1, Linda Yau1, William Reiss1, Benjamin Krämer1, Jeffrey D. Neidhart1, Gerard J. Criner1, Emma Kaplan‐Lewis1, Rachel Baden1, Lavannya M. Pandit1, Miriam L. Cameron1, Julia Garcia‐Diaz1, Victoria Chávez1, Martha Mekebeb-Reuter1, Ferdinando Lima de Menezes1, Reena Shah1, María Fernanda González-Lara1, Beverly Assman1, Jamie Freedman1, Shalini Mohan1
1From Elmhurst Hospital Center-Icahn School of Medicine at Mount Sinai Hospital (C.S.), and Elmhurst Hospital Center-New York City Health and Hospitals (E.K.-L.) - both in New York; Genentech, South San Francisco (J.H., L.Y., W.G.R., B.K., B.A., J.F., S.V.M.), and Highland Hospital, Oakland (R.B.) - both in California; San Juan Oncology Associates, Farmington, NM (J.D.N); Lewis Katz School of Medicine at Temple University, Philadelphia (G.J.C.); Michael E. DeBakey Houston VA Medical Center, Houston (L.P.); Holy Cross Health, Silver Spring, MD (M.L.C.); Ochsner Clinic Foundation, New Orleans (J.G.-D.); Central Military Hospital, Lima, Peru (V.C.); Stellenbosch University, Cape Town, South Africa (M.M.-R); BR Trials-Clinical Research, São Paulo (F.L.M.); Aga Khan University Hospital, Nairobi (R.S.); and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City (M.F.G.-L.).

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1001/jama.2020.1097

World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) global research and innovation forum. 2020 (https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum).

10.1001/jama.2020.2648

10.1016/S0140-6736(20)30211-7

10.1001/jamainternmed.2020.3596

10.1007/s00134-020-05991-x

10.1001/jama.2020.6775

10.1016/S2213-2600(20)30316-7

10.1016/S2213-2600(20)30304-0

10.1056/NEJMoa2021436

10.1016/j.eclinm.2020.100404

Centers for Disease Control and Prevention. Cases data and surveillance — COVID-19 hospitalization and death by race/ethnicity November 30 2020. (https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html).

10.1038/s41586-020-2521-4

10.1056/NEJMp2023616

10.1001/jamainternmed.2020.3857

10.1056/NEJMp2019445

10.1056/NEJMsa2011686

10.1056/NEJMp2012910

10.1016/j.eclinm.2020.100455

10.1056/NEJMp2021971

10.1016/S0140-6736(20)30628-0

10.1016/j.chom.2020.04.009

10.1002/jmv.25948

Zhu J, Pang J, Ji P, et al. Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis. J Med Virol 2020 May 29 (Epub ahead of print).32470146

10.1016/j.jaci.2020.05.008

Actemra prescribing information. South San Francisco CA: Genentech 2019 (package insert).

RoActemra summary of product characteristics. Grenzach-Wyhlen Germany: Roche 2020.

10.1073/pnas.2005615117

10.1016/j.jaut.2020.102512

10.1001/jamainternmed.2020.6252

Rosas I Bräu N Waters M et al. Tocilizumab in hospitalized patients with COVID-19 pneumonia. September 12 2020 (https://www.medrxiv.org/content/10.1101/2020.08.27.20183442v2). preprint.

10.1001/jamainternmed.2020.6615

10.1001/jamainternmed.2020.6820

10.1056/NEJMoa2028836

Department of Health and Human Services. Social determinants of health. 2020 (https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health).

10.1056/NEJMp2005689

10.1056/NEJMp2008193

Centers for Medicare & Medicaid Services. COVID-19 frequently asked questions (FAQs) on Medicare fee-for-service (FFS) billing. 2019 (https://www.cms.gov/files/document/03092020-covid-19-faqs-508.pdf).

National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2020 (https://www.covid19treatmentguidelines.nih.gov/).